Cargando…
Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
As an autosomal dominant disorder, familial hypercholesterolemia (FH) is mainly caused by pathogenic mutations in lipid metabolism-related genes. The aim of this study is to investigate the genetic mutations in FH patients and verify their pathogenicity. First of all, a pedigree investigation was co...
Autores principales: | Hu, Haochang, Shu, Tian, Ma, Jun, Chen, Ruoyu, Wang, Jian, Wang, Shuangshuang, Lin, Shaoyi, Chen, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712701/ https://www.ncbi.nlm.nih.gov/pubmed/34970301 http://dx.doi.org/10.3389/fgene.2021.762587 |
Ejemplares similares
-
The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia
por: Hu, Haochang, et al.
Publicado: (2021) -
In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia
por: Lin, Shaoyi, et al.
Publicado: (2023) -
The promising novel therapies for familial hypercholesterolemia
por: Chen, Ruoyu, et al.
Publicado: (2022) -
Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia
por: Moradi, Arman, et al.
Publicado: (2021) -
Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
por: Idrees, Muhammad, et al.
Publicado: (2018)